Your browser doesn't support javascript.
loading
A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.
Simmons, Danielle A; Belichenko, Nadia P; Yang, Tao; Condon, Christina; Monbureau, Marie; Shamloo, Mehrdad; Jing, Deqiang; Massa, Stephen M; Longo, Frank M.
Afiliación
  • Simmons DA; Department of Neurology and Neurological Sciences and Behavioral and Functional Neuroscience Laboratory, Institute for Neuro-Innovation and Translational Neurosciences, Stanford University School of Medicine, Stanford, California 94305, Department of Psychiatry, Weill Cornell Medical College, New York, New York 10021, and Department of Neurology and Laboratory for Computational Neurochemistry and Drug Discovery, Department of Veterans Affairs Medical Center and Department of Neurology, Universit
J Neurosci ; 33(48): 18712-27, 2013 Nov 27.
Article en En | MEDLINE | ID: mdl-24285878

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzamidas / Enfermedad de Huntington / Receptor trkB / Trastornos del Movimiento Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Neurosci Año: 2013 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzamidas / Enfermedad de Huntington / Receptor trkB / Trastornos del Movimiento Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Neurosci Año: 2013 Tipo del documento: Article